OXBDF (OXBDF) Stock Price & Analysis
OXBDF (OXBDF) rose 0.00% to USD 7.15 as of September 9, 2026 at 21:20 UTC, according to Nexqual real-time market data.
OXBDF last closed at USD 7.15; the session ranged USD 7.15–7.15 on volume of 100 shares. Market capitalization is $865.50M, with a 52-week range of USD 6.88–12.61 (PNK). Source: Nexqual, September 9, 2026 at 21:20 UTC.
Key Statistics (as of September 9, 2026 at 21:20 UTC)
| Price | USD 7.15 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 7.15 |
| Open | USD 7.15 |
| Day Range | USD 7.15 – 7.15 |
| 52-Week Range | USD 6.88 – 12.61 |
| Volume | 100 shares |
| Market Cap | $865.50M |
| Exchange | PNK |
Technical Analysis (OXBDF)
Nexqual's technical model rates OXBDF "SELL" based on 1 bullish and 5 bearish signals across 126 daily candles, as of September 9, 2026 at 21:20 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 33.15 (neutral) |
| vs SMA50 | Below (USD 7.58) |
| MACD | -0.12 (negative) |
Analyst Ratings (OXBDF)
Wall Street analysts rate OXBDF "None", per Nexqual as of September 9, 2026 at 21:20 UTC.
| Consensus Rating | None |
|---|
Earnings (OXBDF)
| Next Earnings Date | 2026-09-22 |
|---|
Source: Nexqual, September 9, 2026 at 21:20 UTC.
Financials & Fundamentals (OXBDF)
| Total Revenue | $168.74M |
|---|---|
| Revenue Growth (YoY) | +22.50% |
| Gross Margin | +39.10% |
| Operating Margin | -7.88% |
| Profit Margin | -17.85% |
| ROE | -40.37% |
| Debt / Equity | 162.16 |
| Current Ratio | 2.2 |
| Total Cash | $96.90M |
| Total Debt | $148.13M |
| Free Cash Flow | $-13,250 |
Source: Nexqual, September 9, 2026 at 21:20 UTC.
Financial Health Score (OXBDF)
Nexqual rates OXBDF's overall financial health "Weak" across five dimensions, as of September 9, 2026 at 21:20 UTC.
| Growth | Strong — Revenue +31% YoY (annual) |
|---|---|
| Profitability | Weak — Gross margin 39%, operating -8% |
| Balance Sheet | Weak — $97M cash vs $148M debt |
| Cash Flow | Weak — FCF negative: -$13K, burning cash |
| Efficiency | Critical — ROE -40%, ROA -7.0% |
Ownership (OXBDF)
| Insider Ownership | +20.55% |
|---|---|
| Institutional Ownership | +63.68% |
| Shares Outstanding | 121.05M |
| Float | 67.59M |
Source: Nexqual, September 9, 2026 at 21:20 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| PHMMF | PHARMA MAR SA | USD 94.6 | ▲ 0% |
| PHGUF | Pharming Group NV | USD 1.1 | ▲ 0% |
| PTCHF | PureTech Health PLC | USD 1.65 | ▲ 5.5% |
| INRLF | Valneva SE | USD 3.29 | ▲ 0% |
| CLVLF | Clinuvel Pharmaceuticals Ltd. | USD 5.89 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 9, 2026 at 21:20 UTC. This page is informational and not investment advice.